Jump to content

Target Identification in Triple Negative Breast Cancers with Genedata Profiler

January 16, 2018 - Dr. Marisa Fernandez, Scientific Account Manager at Genedata

Genedata Profiler is used to identify targets for triple negative breast cancer treatment (TNBC). Raw omics datasets (RNA-Seq and DNA-Seq) are processed and integrated with phenotype data to generate targets for TNBC treatment.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy